RNA Interference and Viruses: Current Innovations and Future Trends
Miguel Angel Martínez
Horizon Scientific Press, 2010 - Science - 252 pages
Since its discovery in 1998, RNA interference (RNAi) has heralded the advent of novel tools for biological research and drug discovery. This exciting new technology is emerging as a powerful modality for battling some of the most notoriously challenging viral clinical targets, such as the hepatitis C virus (HCV) and the human immunodeficiency virus (HIV). However, several critical issues associated with this novel technology must be resolved before it can progress to testing in human clinical trials, and these have been the target of intensive research in recent years. In this book, expert RNAi specialists from around the world have teamed up to produce a timely and thought-provoking review of the area. The two central themes are: 1) the latest findings on RNAi-virus interactions and 2) progress in the development of RNAi-based antiviral therapeutics. A number of chapters explain general concepts concerned with the role of RNAi in natural antiviral defense mechanisms. Other chapters discuss how to improve the efficacy and safety of RNAi-based antiviral drugs, as well as describe how this technology is being developed as a new therapeutic tool for fighting specific viruses, including HIV, HCV, and respiratory viruses. The book also outlines potential new avenues for research. RNA Interference and Viruses is essential reading for researchers involved in RNAi or antiviral research and is a recommended text for all virology laboratories.
What people are saying - Write a review
We haven't found any reviews in the usual places.
RNAi an Antiviral Defence System in Insects
RNA Silencing in Plants and the Role of Viral Suppressors
The Properties and Roles of Virusencoded MicroRNAs
Virusencoded Suppressors of RNA Silencing and the Role of Cellular miRNAs in Mammalian Antiviral Immune Responses
HCV and the Interaction with miR122 in the Liver
Viral Escape from RNAi in Mammalian Cells
RNAi Gene Therapy to Control HIV1 Infection
Acad activity adenovirus antisense antiviral antiviral RNAi Berkhout binding Biol cellular miRNAs Chen chronic cleavage complex Cullen cytoplasm delivery Dicer double-stranded down-regulation Drosophila melanogaster dsRNA duplex effects efficient encoded endogenous function gene expression gene silencing gene therapy genetic genome Haasnoot HCV replication HCV RNA hepatitis C virus host human immune response induce inhibition inhibitors interaction Jopling lentiviral lentiviral vector liver mammalian cells mechanism mediated mice microRNA miRNAs molecules mRNA mutations Natl Nucleic Acids nucleotides pathogens plants polymerase potential pre-miRNA Proc promoter protein receptor regulation replicon RISC RNA interference RNA silencing RNAi RNAi machinery RNAi pathway RNAi-based role shRNA silencing suppressor siRNAs small interfering RNAs small RNAs specific strand studies suppression target sequence therapeutic tion transcription transgenic translation viral escape viral genome viral miRNAs viral RNA viral vectors Virol virus infection virus replication vivo Voinnet Wang Zhang